Market Signals and Stock Highlights: Spotify and CRISPR Therapeutics

More than 5 million more Americans file for unemployment as the monthly total surpasses 22 million. Abbott Labs gets a boost on optimism over its coronavirus testing. Gilead Sciences gets a boost on optimism over its coronavirus treatment. Procter & Gamble reports its biggest U.S. sales gain in decades. Amazon hits an all-time high. Comcast launches a preview of its Peacock streaming service. And Verizon buys BlueJeans Network, a videoconferencing company. Motley Fool analysts Jason Moser and Ron Gross discuss those stories, take stock in the banking and airline industries, and weigh in on some dividend hikes. Plus, the guys share a few stocks on their radar: Spotify and CRISPR Therapeutics. And Okta co-founder and COO Frederic Kerrest talks cloud-based security software, password protection, and misconceptions about entrepreneurs.

Learn more about your ad choices. Visit megaphone.fm/adchoices